Bilateral pelvic lymph node dissection for Chinese patients with penile cancer: a multicenter collaboration study
- PMID: 27771796
- PMCID: PMC11819431
- DOI: 10.1007/s00432-016-2292-3
Bilateral pelvic lymph node dissection for Chinese patients with penile cancer: a multicenter collaboration study
Abstract
Background: Current guidelines recommend pelvic lymphadenectomy (PLND) for patients with pelvic lymph node metastasis and special state. However, these data and recommendations do not distinguish the role of PLND in different patient groups and confirm the final benefits. The aim of this study was to confirm the efficacy of pelvic lymphadenectomy (PLND) for the different groups of patients.
Methods: Data obtained from 7 centers were retrospectively analyzed. Of the patients, 190 pN2-3 penile carcinoma patients confirmed by bilateral inguinal lymph node excision were included in this study. Sixty-nine and 121 of these patients did and did not undergo bilateral PLND, respectively. The baseline differences from the patients were matched by propensity score analysis.
Results: In this study, the Kaplan-Meier estimated disease-specific survival (DSS) was not significantly different between the PLND and no-PLND groups (P = 0.796). According to the propensity score matching for T stage, N stage, grade, adjuvant therapies, and lymph node stage (number of inguinal lymph node metastasis and extranodal extension), 48 patients were selected for each group. Among the pN2 patients, the PLND group showed higher DSS rates than the no-surgery group (P = 0.030). However, even after matching, survival did not differ between the PLND and no-PLND patients among all patients (P = 0.609) and pN3 patients (P = 0.417) with comparable DSS.
Conclusion: Bilateral PLND may improve survival in pN2 patients. Men with pN3 may not benefit from bilateral PLND.
Keywords: Lymph node excision; Mortality; Neoplasm metastasis; Penile neoplasms.
Conflict of interest statement
All of the authors declare that they have no conflict of interest.
Figures


References
-
- Clark PE (2015) NCCN clinical practice guidelines in oncology (NCCN Guidelines) penile cancer. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#penile
-
- D’Agostino RJ (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17:2265–2281 - PubMed
-
- Di Lorenzo G, Buonerba C, Federico P, Perdona S, Aieta M, Rescigno P et al (2012) Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis. BJU Int 110:E661–E666 - PubMed
-
- Djajadiningrat RS, van Werkhoven E, Horenblas S (2015) Prophylactic pelvic lymph node dissection in patients with penile cancer. J Urol 193:1976–1980 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources